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ABSTRACT
CAENORHABDITIS ELEGANS MODEL TO STUDY ANTIMICROBIAL TREATMENT
ON E. COLI O157:H7
MAY 2018
PARITA R PATEL, B.S., WESTERN MICHIGAN UNIVERSITY
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Lynne A. McLandsborough

An increase in antimicrobial resistance bacteria has endangered our ability
to treat infectious diseases. Lack of good in-vivo model has made it difficult to study
antimicrobial resistance. In this study, we have used an inexpensive and short life
span in-vivo model namely, Caenorhabditis elegans (C. elegans) to study
antimicrobial treatment using pathogenic Escherichia coli O157:H7, a multidrug
resistance bacterium that causes life threatening infection in humans.
We have investigated the influence of live vs. heat killed non-pathogenic E.
coli OP50 (OP50) as a food source on the growth and survival of infected C. elegans
mutant AU37 with E. coli O157:H7 in the presence and absence of antibiotics. This is
analyzed using a liquid-based C. elegans-E. coli O157:H7 infection assay. C. elegans
was synchronized and grown on a lawn of live OP50 till they reached L4-young
adult stage. L4-young adults were transferred to liquid medium where the C. elegans
was infected with live E. coli O157:H7 or live non-pathogenic OP50 for 24 hours.
After infection, C. elegans were fed live or heat killed OP50 depending on the
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experiment, and the life span and levels of E. coli O157:H7 were monitored, with and
without ampicillin treatment in a 96 well transwell plate.
Our results indicate that live OP50 is an ideal food source for C. elegans
growth and survival to study antimicrobial treatment. C. elegans growth rate and
survival decreased in presence of heat killed OP50, which makes heat killed OP50 as
a non-ideal food source for antimicrobial assay. Moreover, using live OP50 we have
discovered that the ampicillin dose 8µg/ml, 16µg/ml, and 32µg/ml are effective in
increasing the survival of C. elegans infected with E. coli O157:H7. However,
treatment on C. elegans infected with acid stressed E. coli O157:H7 is controversial.
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CHAPTER 1
INTRODUCTION

Enterohemorrhagic E. coli (EHEC) is one of the groups of pathogenic E. coli,
capable of causing hemorrhagic colitis (bloody diarrhea) and hemolytic uremic
syndrome (HUS) (acute kidney failure) in humans (Lim et al., 2010). EHEC is also
referred to as Shiga-toxin producing E. coli (STEC) because of its ability to produce
Shiga-toxins. E. coli O157:H7 is one of the serotypes of EHEC, recognized as the
leading cause of EHEC outbreaks in the United States (Ho et al., 2013). Treatment
with E. coli O157:H7 is self-limiting, as clinical studies indicate controversial results
on the use of antibiotics to increase the risk of development of HUS (Panos et al.,
2006). Lack of good in-vivo model has limited the study of EHEC infection and
treatment. In this study, we have used an in-expensive in-vivo model namely
Caenorhabditis Elegans (C. elegans) to study E. coli O157:H7 infection and treatment.
Lately, C. elegans has gained popularity to study bacterial pathogenicity
because of the simplicity of the model. C. elegans is inexpensive, small in size
(»1mm), have short life-span of approximately 3 weeks, and can produce a large
number of offspring in short time (Corsi et al., 2015). In addition, it has 65% of the
genes that are related to human diseases and has its entire genome sequenced (Shen
et al., 2017). All these characteristics of C. elegans make them an excellent model to
study bacterial pathogenicity.
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The main goal of this research is to develop a C. elegans infection-treatment
model to evaluate the sensitivity of E. coli cells to the ampicillin treatment in in-vivo
model. If we will be successful in developing the C. elegans infection system, we can
use the system to study acid stressed E. coli O157:H7 infection using C. elegans
model, which is to be likely associated with EHEC infection as the cells needs to pass
through our stomach acid to colonize our gut. In addition, we can use different
antimicrobials to study antimicrobial resistance in E. coli O157:H7, as well as in
other food-borne pathogens.
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CHAPTER 2
LITERATURE REVIEW
2.1 Enterohemorrhagic Escherichia coli O157:H7
Escherichia coli (E. coli) is a facultative anaerobic gram-negative rod-shaped
bacterium. Most E. coli strains are harmless and are present as a normal flora in the
gastrointestinal tract of humans and animals (Lim et al., 2010). However, some E.
coli strains have evolved into pathogens, and are capable of causing severe illness to
humans.
Pathogenic E. coli has been divided into various groups based on serogroup,
pathogenicity mechanisms, clinical symptoms, and/ or virulence factors (Lim et al.,
2010). There are six groups characterized as pathogenic E. coli: Enterohemorrhagic
E. coli (EHEC) also referred to as Shiga toxin-producing E. coli (STEC),
Enterotoxigenic E. coli (ETEC), Enteropathogenic E. coli (EPEC), Enteroaggregative
E. coli (EAEC), Enteroinvasive E. coli (EIEC), and Diffusely Adherent E. coli (DAEC)
(CDC, 2014). Among this groups, Enterohemorrhagic Escherichia coli (EHEC) is most
commonly associated with the foodborne outbreaks (CDC, 2014). EHEC have many
serotypes O26, O45, O91, O103, O111, O121, O145, and O157 (Barlow and Mellor,
2010). Escherichia coli serotype O157:H7 is the most common cause of EHEC
outbreaks in the United States (Ho et al., 2013). EHEC is estimated to cause about
265,000 illnesses in the United States, among which E. coli O157:H7 accounts for
about 36% of the illnesses (CDC, 2014).
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One of the major pathogenic factors of E. coli O157:H7 is the ability to
produce Shiga toxin (Tarr et al., 2005). However, term EHEC is specifically referred
to the serotype that produce Shiga toxins, and cause hemorrhagic colitis (HC) and
hemolytic uremic syndrome (HUS) in humans (Lim et al., 2010). HUS is the leading
cause of acute renal failure in children (Hu et al., 2013).
E. coli O157:H7 can grow at a temperature as low as 7°C and as high as 50°C,
with an optimum growth temperature at 37°C (WHO, 2018). It can grow in an acidic
condition at pH as low as 4.4 (WHO, 2018). E. coli O157:H7 activates regulatory
factor RpoS which helps the bacteria survive in acidic stress condition (Jordan et al.,
1999). In addition, arginine and glutamate-dependent system are also known to
play an important role in the survival of E. coli O157:H7 in acidic foods (Jordan et al.,
1999).
EHEC can be destroyed through thorough cooking, as it doesn’t survive at a
temperature higher than 70°C (WHO, 2018). Young children, elderly, and
immunocompromised individuals are more susceptible to EHEC infection (WHO,
2018). While some individuals have asymmetric infections, others can develop
severe infections associated with bloody diarrhea and abdominal cramps within
three days of consuming contaminated food (Hu et al., 2013). Symptoms last an
average of 3-4 days, with a maximum duration of 10 days (CDC, 2014).
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2.1.1 E. coli O157:H7 History
E. coli O157:H7 was first recognized as a human disease in 1982, during
undercooked hamburger outbreak, where E. coli O157:H7 was known as causing
hemorrhagic colitis (bloody diarrhea), non-bloody diarrhea, and HUS (Kaper et al.,
2004). However, it has gained public attention in the United States after Jack-in-theBox outbreak in 1993, which has resulted in more than 700 illnesses and 4 deaths
(Armstrong et al., 1996). Since then, many outbreaks associated with EHEC infection
has been reported. Table 1 shows E. coli O157:H7 outbreaks in the United States
since last five years from 2013-2017 (CDC, 2018).
Table 1 E. coli O157:H7 outbreaks associated with food from 2013-2017 (CDC,
2018).
Outbreaks (Year)

Food associated with E.
coli O157:H7 outbreak

Number of people
infected

2017

Romaine Lettuce

25

SoyNut Butter

32

Beef Products

11

Sprouts

11

2015

Chicken Salad

19

2014

Ground Beef

12

2013

Ready to eat Salad

33

2016
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2.1.2 Transmission of E. coli O157:H7 to humans
E. coli O157:H7 is a human pathogen, however, it is present as a normal flora
in the intestinal tract of ruminants such as cattle, sheep, goat, and deer (Hu et al.,
2013). Human exposure to E. coli O157:H7 is associated with ingestion of
contaminated food such as undercooked ground beef and raw milk (WHO, 2018). In
addition, E. coli O157:H7 is transmitted to humans through fecal contamination of
water and food such as fruits and vegetables, cross-contamination during food
preparation, and even with person-person contact (Hu et al., 2013; WHO, 2018).
2.1.3 EHEC Colonization, Diagnosis, and Treatment
In humans, EHEC infection develops when the bacteria colonize the
gastrointestinal tract. The physical structure of the E. coli O157:H7 contains
fimbriae which helps the bacteria adhering to the intestinal epithelial cells (Kaper et
al., 2004).
In humans, E. coli O157:H7 infection can be detected by culturing stool
sample on selective/differential sorbitol-MacConkey agar (Tarr et al., 2005). E. coli
O157:H7, unlike other non-pathogenic E. coli strains, cannot ferment sorbitol and
hence can appear colorless/ beige colonies on sorbitol-MacConkey agar after
overnight incubation at 37°C (Tarr et al., 2005).
In vitro studies have shown antibiotics to be effective against E. coli O157:H7,
however, sub-lethal antibiotic concentration can increase the release of Shiga toxins
and hence the development of HUS (Panos et al., 2006). In humans, hydration is the
only recommended treatment for EHEC infection (CDC, 2014). Treatment with
6

antibiotics is controversial as some clinical studies indicate that antibiotics
treatment increases the risk of development of HUS while some studies indicate
antibiotics as effective in reducing the duration of the infection and may prevent the
development of HUS (Panos et al., 2006). Here we proposed an inexpensive and
simple in-vivo model Caenorhabditis Elegans (C. elegans) to study pathogenicity and
antimicrobial treatment.
2.2 Caenorhabditis Elegans
Caenorhabditis Elegans (C. elegans) is a small free-living transparent soil
nematode with about 1mm adult in length (Corsi et al., 2015). Nematodes can be
observed using a dissecting microscope, which generally has 100x magnification
(Corsi et al., 2015). It can easily cultivate in the laboratory with non-pathogenic E.
coli OP50 as food (Riddle et al., 1997). C. elegans can reproduce in 2-4 days
depending on strain and incubation temperature (Riddle et al., 1997). It has two
sexes, male (rare) and a self-fertilizing hermaphrodite which can produce up to 300
offspring (Corsi et al., 2015). Their lifespan on average is up to 2-3 weeks at 25°C
(Fielenbach and Antebi, 2008). Furthermore, C. elegans has a fully sequenced
genome, which makes them suitable for genetic studies (Godballe et al., 2010).
Research involving C. elegans does not need permission from Institutional Animal
Care and Use Committees (Shen et al., 2017). Most importantly, C. elegans conserve
more than 65% of the genes that are related to human diseases (Shen et al., 2017),
which makes them a suitable animal model to study human bacterial infection.
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Figure 1 Anatomy of C. elegans. (A) Hermaphrodite (B) Male (Corsi et al., 2015)
(www.wormbook.org) Licence by: https://creativecommons.org/licenses/by/2.5/
2.2.1 Anatomy and Life-cycle of C. elegans
The body shape of C. elegans is unsegmented, cylindrical with an outer tube
separated from an inner tube (Figure 1) (Altun and Hall, 2009; Corsi et al., 2015;
Godballe et al., 2010). The outer tube of C. elegans contains the cuticle, hypodermis,
excretory system, neurons, and muscles, where inner tube contains the pharynx,
intestine, and gonad in adult (Altun and Hall, 2009; Godballe et al., 2010). The
pharynx is one of the important part of the C. elegans as it protects worms against
bacterial infection (Godballe et al., 2010). The grinder in the pharynx grinds the
bacteria and prevent the whole bacteria from reaching to the intestine (Godballe et
al., 2010). Besides C. elegans anatomy, its ability to sense different chemical signal as
a nutrient or toxin helps them to stay away from the pathogens and pathogens does
not have easy access to the C. elegans intestine (Godballe et al., 2010).
C. elegans has a rapid 3-5 days life-cycle (from egg to adulthood) at
temperature 15°C - 20°C (Fielenbach and Antebi, 2008). Typical C. elegans life-cycle
8

consists of four larval stage from L1 to the L4 stage, and then adulthood (Figure 2).
It is a good laboratory model to use for life-span study because it is easy to
synchronize with the growth halt at the L1 stage in the absence of food. When food
is available, worms can grow from the L1 to L4 stage after 45-50 hours at 25°C. L4
stage worms can be recognized under dissecting microscope with its unique
appearance having white vulva area. In overcrowding and lack of food condition, it
can go to dauer stage where it can survive up to 4 months without food and can
again start to feed and reaches to the L4 stage. As the dauer can survive for months,
it can be kept as a stock in a petri dish at 15°C (Corsi et al., 2015).

Figure 2 Life cycle of C. elegans (Altun and Hall, 2009)
(http://www.wormatlas.org).
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2.2.2 C. elegans as a model for E. coli O157:H7 infection and treatment
In a laboratory, C. elegans can easily grow on a petri dish and fed on nonpathogenic bacterial strain E. coli OP50. C. elegans can be used to study EHEC
infection simply by replacing its food with pathogenic bacteria. However, it is
important to understand C. elegans behavioral response to bacterial food as C.
elegans can sense the difference between the nutrient and toxin (Godballe et al.,
2010).
Many human bacterial pathogens kill C. elegans by colonizing their intestine,
and the pathology is measured as a decrease in the life-span of C. elegans (Darby,
2005). Hence, C. elegans intestinal bacterial colonization can be quantified using
plate count method. E. coli OP50 does not colonize the C. elegans intestine (Darby,
2005). Bacterial pathogens can kill C. elegans by releasing the toxin (fast-killing) or
by colonizing the C. elegans intestine (slow killing) (Darby, 2005).
As C. elegans conserve about 65% of the genes related to the human diseases
(Shen et al., 2017), has its full genome sequenced (Godballe et al., 2010), and
because of the simplicity of the model, C. elegans is widely used in pathogenicity and
human diseases study. Previous research on plate-liquid infection assay has shown
that enterohemorrhagic E. coli (EHEC), enteroaggregative E. coli (EAEC),
enteropathogenic E. coli (EPEC), and uropathogenic E. coli (UPEC) is pathogenic to C.
elegans (Chou et al., 2013; Merkx-Jacques et al., 2013). Here, we propose a liquidliquid infection-treatment assay as a simple experimental procedure to study the
antibiotic treatment of E. coli O157:H7.
10

CHAPTER 3
OBJECTIVES

1. To determine if heat-killed E. coli OP50 is a good food source for C. elegans
compared to live E. coli OP50 in infection-treatment assay.
2. To determine if C. elegans is an appropriate model to study E. coli O157:H7
infection and treatment in-vivo.
3. To determine if ampicillin treatment is effective in worms infected with acid
stressed E. coli O157:H7 cells compared to the worms infected with non-acid
stressed E. coli O157:H7 cells.
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CHAPTER 4
MATERIALS AND METHODS
4.1 Bacterial strains, media and preservation
Bacterial strain non-pathogen E. coli OP50 (OP50) was used as nematode
food and was obtained from Dr. Park Lab, University of Massachusetts, Amherst.
Bacterial strain pathogen E. coli O157:H7 (laboratory number E21B) was used to
infect worms and was obtained from American Type Culture Collection (ATCC)
(ATCC 43895, Manassas, VA).
Concentrated E. coli OP50 used as nematodes food in 96 Transwell (Corning
HTS Transwell 96 well pore size 0.4µm, Sigma-Aldrich, St. Louis, MO) was prepared
by mixing a loop full of OP50 culture from a streaked plate into 200ml Luria-Bertani
broth (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) and incubated at
37°C overnight on a 125rpm shaker. Then, the mixture was centrifuged (Sorvall ST 8
small benchtop centrifuge with TX-150 swinging bucket rotor (Thermo Fisher
Scientific Inc., Waltham, MA) at 2,500g for 10 minutes and the supernatant was
discarded. OP50 pellet was concentrated to 100 mg/ml in a sterilized water (Solis
and Petrascheck, 2011). The culture was stored at -20°C. Heat-killed OP50 was
prepared by incubating concentrated OP50 in 70°C hot bath for 30 minutes (Ren et
al., 2009).
Frozen bacterial stock, E. coli OP50 and E. coli O157:H7, were prepared for
long-term storage. Bacterial culture was grown overnight in a Tryptic Soy Broth
(TSB) (Becton, Dickinson and Company, Franklin Lakes, NJ, USA). Sterile glycerol
12

(50% glycerol w/v in dH2O) was added at a proportion of 1-part glycerol:1-part TSB
containing bacterial culture and mixed into a small sterile tube. The mixture was
stored at -80°C. Tryptic Soy Agar (TSA) (Becton, Dickinson and Company, Franklin
Lakes, NJ, USA) plate was streaked from the frozen stock each time for the new
experiment. The streaked plates were discarded after a week.
4.2 Nematode strains, media and preservation
Caenorhabditis elegans (C. elegans) strain AU37 was purchased from
Caenorhabditis Genetics Center (CGC, University of Minnesota, Minneapolis, MN).
Some strains were provided by the CGC, which is funded by NIH Office of Research
Infrastructure Programs (P40 OD010440). Strain AU37 is a double mutant (glp-4
(bn2ts); sek-1(km4)), where glp-4 is a temperature-sensitive mutation that does not
allow proliferation at 25°C and sek-1 is a mutation that increases C. elegans
susceptibility to pathogens (Zhou et al., 2011). C. elegans mutant AU37 were
maintained at 15°C. C. elegans strain N2, wild-type strain, was obtained from Dr.
Park Lab, University of Massachusetts, Amherst.
Nematode growth medium agar plates (NGM, US Biological Life Sciences Inc.,
Salem, MA, prepared with 1M Calcium Chloride, 1M Dipotassium Phosphate (SigmaAldrich, St. Louis, MO), and 1M Magnesium Sulfate (Thermo Fisher Scientific Inc.,
Waltham, MA)) were prepared according to the manufacturer’s instructions. E. coli
OP50 was grown at 37°C in a Luria-Bertani broth for 12-14 hours on a 125rpm
shaker and 1 ml of overnight culture was added to the center of NGM agar plates.
The plates were incubated at room temperature for 48 hours, to allow for growth
13

(considered as NGM seeded with OP50). After 48 hours, plates were sealed in a
plastic bag to prevent contamination and moisture loss and moved to 4°C incubator.
Nematode working cultures were prepared by transferring a piece of an NGM
agar containing C. elegans to a NGM plate seeded with OP50 and incubated at 15°C
for 4-5 days. When the working culture plate contained many L1 stage worms (as
determined by observation with a dissecting microscope), the plate was sealed with
parafilm to prevent contamination and loss of moisture and stored at 15°C. The
plate was kept for about two months and then discarded. New working culture
nematodes were prepared using the same procedure, from an old NGM plate
containing many worms.
4.3 Synchronization of worms
Worms were synchronized following the protocol described by Stiernagle,
with some modification (2006) (wormbook.org). Synchronized worms were
prepared by placing a section of NGM agar containing worms onto a new NGM plate
seeded with OP50 and incubated at 15°C. When large numbers of eggs laid, eggs
were collected by washing the plate with sterile water and collecting the mixture
into a 15ml sterile centrifuge tube. The tube containing worms and eggs were
centrifuged at 2000g for 2 minutes and the supernatant was discarded. The pellet
was suspended in 10 ml bleach solution (18% household bleach (The Clorox
Company, Oakland, CA) and 10% NaCl (Thermo Fisher Scientific Inc., Waltham, MA)
in a sterile water) and vortexed for 2-2.5 minutes at high speed to destroy worms,
then centrifuged (2000 g, 1 min), and supernatant was discarded. Pellet containing
14

eggs was suspended in M9 buffer (5.8g Na2HPO4, 2g KH2PO4, 0.5g NaCl, and 1g
NH4Cl (Thermo Fisher Scientific Inc., Waltham, MA) per 1L distilled water (Ahringer,
2006; Stiernagle, 2006)) to neutralize the reaction, centrifuged (2000g, 2 mins), and
supernatant was discarded. Pellet was re-suspended into an M9 buffer, centrifuged
(2000g, 2 mins), and the supernatant was discarded. Washed eggs were suspended
into a 1ml M9 buffer and incubated at 25°C to hatch. After 24 hours, hatched eggs
(now L1 stage worms) were transferred onto NGM plate seeded with live OP50.
Worms were grown to sterile L4-young adult at 25°C which was typically achieved
after a 45-50 h incubation. Mutant AU37 does not produce eggs at 25°C.

4.4 Determination of minimal inhibitory concentration
Minimal inhibitory concentration (MIC) in-vitro was performed to determine
the lowest concentration of ampicillin that inhibits E. coli O157:H7 growth, to treat
C. elegans infected with E. coli O157:H7. The antimicrobial effectiveness of ampicillin
on E. coli O157:H7 was measured using broth microdilution method described by
Reimer et al. with little modification (1981). E. coli O157:H7 was grown in a MuellerHinton Broth (MHB) (Becton, Dickinson and Company, Franklin Lakes, NJ, USA)
overnight and then diluted 1:10 to measure the absorbance at 625nm. 0.85% NaCl
was used as a blank solution. The test was performed in a 96 well microtiter plate
(Corning Incorporated, Corning, NY) in which 50µl MHB was added to each well, and
a two-fold serial dilution of ampicillin was performed. Then, 50µl of an overnight E.
coli O157:H7 culture was added to each well. The final concentrations of ampicillin
15

were ranging from 0.25µg/ml to 64µg/ml. The microtiter plate was incubated at
37°C for 20-24 hours, and the absorbance was measured at 625nm using ELx800
Microtiter Plate Reader (BioTek Instruments Inc., Winooski, VT). Ampicillin stock
was prepared by filter sterilizing 512mg/ml ampicillin in a sterilized water using
0.22 µm filter. The stock was stored in 100µl volume at -20°C.

4.5 Bacterial colonization
Worms intestinal bacterial colonization was determined as described by Moy
et al. (2006). Approximately 10 worms were collected in a small centrifuge tube and
washed 3 times with approximately 250µl of 1mM sodium azide (Acros Organics,
Thermo Fisher Scientific, NJ, USA). 50µl of the supernatant was plated onto Sorbitol
MacConkey agar (OXOID LTD., Basingstoke, Hampshire, England) to determine the
external CFU. Approximately 400mg of 1.0mm silicon carbide particles (BioSpec
Inc., Bartlesville, OK, USA) was added to the tube and vortexed at high speed for
approximately one minute to disrupt the worms. The suspension was then diluted
and plated onto Sorbitol MacConkey agar. The plates were incubated at 37°C for 2024 hours and the internal CFU/ worm was determined.

4.6 E. coli O157:H7 growth curve
E. coli O157:H7 growth curve was performed to determine the time required
for E. coli O157:H7 grown in Luria-Bertani broth with pH 6.80±0.10 and pH
5.25±0.05 to reach to the late-exponential stage. Luria-Bertani broth pH was
16

adjusted using 99.5% pure acetic acid (Acros Organics, Thermo Fisher Scientific, NJ,
USA) (Deng et al., 1999). E. coli O157:H7 was grown on a Luria-Bertani broth
without pH adjustment (pH 6.80±0.10) for 18-20 hours at 37°C, centrifuged at
2500g for 10 minutes, and the supernatant was discarded. M9 buffer was added to
make the final E. coli O157:H7 concentration of 105 CFU/ml. E. coli O157:H7
concentration of 105 CFU/ml was then added to the pH adjusted (pH 5.25±0.05) and
non-pH adjusted (pH 6.80±0.10) Luria-Bertani broth to make the final bacterial
concentration of 104 CFU/ml. These enrichments were incubated at 37°C and the
absorbance was taken at a wavelength of 625nm every hour to plot an E. coli
O157:H7 growth curve.

4.7 C. elegans-E. coli O157:H7 infection lifespan assay
The lifespan assay was carried out by synchronizing the worms to the L4young adult stage as described in “synchronization of worms” section. NGM plate
containing L4-young adult stage worms were washed using an M9 buffer and
suspended into a sterile 2ml microcentrifuge tube, centrifuged (2000g, 2min) using
accuSpin Microcentrifuge with fixed angle rotor (Fisher Scientific, Waltham, MA),
and the supernatant was discarded. The worms were washed (centrifuged at 2000g,
2 min) at least three times with M9 buffer. Approximately 100 AU37 worms were
added to each well in 24 well plate, containing 109 CFU of E. coli OP50 (refer to as
control) and 109 CFU of E. coli O157:H7 (refer to as infected), each in 1ml M9 buffer
(v/v). For N2 worms, 120µM fluorodeoxyuridine (FUDR) (Tokyo Chemical Industry
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CO., LTD., Portland, OR) was added to the final concentration of 1ml to make worms
infertile (Solis and Petrascheck, 2011). The plate was incubated at 25°C for 24
hours. After 24 hours, both control and infected worms were suspended into a
micro-centrifuged tube and washed at least three times with M9 buffer.
Approximately 10 infected worms were suspended in a 2ml micro-centrifuge tube
to determine the internal bacterial colonization count. Bacterial colonization count
was determined as described in section 4.5.
The treatment was performed in 96 well trans-well with varied
concentration of ampicillin (8µg/ml, 16µg/ml, and 32µg/ml). The control and
infected worms without ampicillin, and with ampicillin (8µg/ml, 16µg/ml, and
32µg/ml) were used to compare the results. Live or heat-killed OP50 were used as
nematodes food depending on an experiment. Each treatment was performed in five
duplicates. The initial number of worms in each well were counted and the plate
was incubated at 25°C. The number of worms alive in each well were counted every
other day till all worms died. The food in the wells was changed as needed. The
experiment was repeated independently. Refer to Appendix A for detailed
experimental procedure.

4.8 Heat stress assay
Heat stress assay was performed similarly as described in section 4.7., with
little modification. After treatment, number of worms alive were counted in 96 well
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transwell plate and the plate were incubated at 37°C. The number of worms alive
was counted every 60 to 90 minutes.

4.9 Acid stress assay
Acid stress assay was performed in a similar manner as mentioned in section
4.7., with little modification. E. coli O157:H7 and E. coli OP50 cells were grown
overnight on Luria-Bertani medium (pH = 5.25 ± 0.05). E. coli O157:H7 and E. coli
OP50 cells were also grown in Luria-Bertani broth without pH adjustment (pH =
6.65 ± 0.05), which will refer to as infected control. E. coli O157:H7 and E. coli OP50
cells were grown to the late exponential stage, the pellet was collected, and the
supernatant was discarded. The pellet was then suspended into an M9 buffer and
the worms were fed with 106 CFU E. coli O157:H7 and E. coli OP50 concentration per
1ml of M9 buffer (v/v).

4.10 Statistical Analysis
Statistical Analysis was performed using the Graph Pad Prism version 7.0c
for Mac OS X (GraphPad Software, Inc.). Log-rank (Mantel-Cox) and Gehan-BreslowWilcoxon test were performed to analyze the significant difference in survival
curves. P-value < 0.05 is considered as significantly different.
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CHAPTER 5
RESULTS AND DISCUSSION

5.1 C. elegans mutant AU37 is preferable in infection assay compared to wild
type N2
Infection assays using E. coli O157:H7 (E21B) were performed with C.
elegans strains AU37 (mutant) and N2 (wild type). C. elegans strain AU37 is a double
mutant strain, with temperature sensitivity and an increased susceptibility to
pathogens (Zhou et al., 2011). Both C. elegans strains, AU37 and N2, were exposed to
E21B or E. coli OP50 (OP50, non-pathogenic negative controls) for 24 hours in an
M9 buffer, worms were recovered, and transferred to 96 well plate (T=0), and the
worms were fed heat-killed OP50 during the duration of the experiment. E21B, an
enterohemorrhagic E. coli, was expected to infect and shorten the life-span of the
worms, while non-pathogenic OP50 was used as a negative control and was not
expected to shorten the life-span.
The survival of C. elegans AU37 infected with E. coli O157:H7 had a reduced
life-span compared to the AU37 infected with non-pathogenic E. coli OP50, however
the differences were not significant (P>0.05) (Figure 3A). The survival of C. elegans
N2 infected with E21B was not different compared to OP50 (Figure 3B). The results
indicated that E21B may successfully infect AU37; however, it may fail to infect N2.
We are not sure whether E21B can infect and colonize the N2 strain later in the life
of worms since the assay was terminated for N2 after 19 days, when all AU37 died.
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Based on the 19 days life-span study, N2 is not susceptible to E21B infection. Chou
et al. has showed E. coli O157:H7 does colonize N2 worms (2013). However, in
order to shorten the experimental duration, we concluded that the AU37 is more
suitable for infection assay.
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Figure 3 Infection assay with E. coli O157:H7. Worms were grown to L4/ young
adult stage and transferred to 24 well plate containing 109 CFU/ml E. coli O157:H7
in M9 buffer or similar levels of E. coli OP50. Worms infected with E. coli O157:H7
and E. coli OP50 for 24 hours. Worms were recovered and transferred to a 96 well
trans-well plate (T=0) containing heat-killed OP50 as a food source for the
remainder to the experiment at 25°C and survival was counted every day for 19
days. Graph Pad Prism Log-rank (Mantel-Cox) test was used to obtain the p-value.
(A) AU37 (p=0.2781) (B) N2 (p=0.5954). P-value of less than 0.05 is considering to
be statistically different.
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5.2 Heat-killed OP50 significantly decreases the life-span of C. elegans strain
AU37
We originally tested the C. elegans AU37 infection assay using heat-killed
OP50 as post-infection food in trans-well plate. This was done due to the concern
that live non-pathogenic bacteria (OP50) will interfere with live pathogenic bacteria
(E21B) and will mislead the intestinal colonization numbers in worms. In addition,
the goal was to develop an in-vivo infection assay for antibiotic efficiency; we were
concerned that the antibiotic will also kill OP50, which may complicate the system.
C. elegans AU37 fed with heat-killed OP50 had a significantly shorter the lifespan compared to the worms fed with live OP50 (Figure 4). When a preliminary
study was done with synchronized worms (L1 stage) fed with heat-killed OP50 vs.
live OP50 on NGM lawn, we observed the worms fed with live OP50 has reached to
L4/ young adult stage within 48 hours, whereas worms fed with heat-killed OP50
were significantly smaller, and we hypothesize they may possibly move to a dauer
stage (Figure 5). This indicates that live OP50 is needed to provide sufficient
nutrient to the C. elegans AU37 for its growth and survival. Live OP50 were used to
feed C. elegans AU37 after infection in all subsequent experiments.
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Figure 4 AU37 survival assay fed with live vs. heat-killed OP50. Worms were grown
to L4/ young adult stage and transferred to 96 trans-well plate where worms were
fed with live vs. heat-killed OP50. Survival was counted every day till all worms
died. Graph Pad Prism Log-rank (Mantel-Cox) (P=0.0032) and Gehan-BreslowWilcoxon (P=0.0100) tests were used to obtain a p-value.

700µm

400µm

Figure 5 Dissecting microscope image of AU37 after 48 hours. Worms were
synchronized and transferred to the NGM plate containing lawn of live vs. heatkilled OP50 after 24 hours. Dissecting microscopic image was taken using a digital
camera (AmScope MU1400 with FMA050 lens, AmScope, Irvine, CA) after 48 hours.
Image shown are at highest magnification. (A) AU37 grown on a live OP50 lawn. (B)
AU37 grown on a heat-killed OP50 lawn.
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5.3 Ampicillin treatment significantly increases the life-span of infected
worms
In order to determine whether C. elegans is an appropriate model to study E.
coli O157:H7 infection and treatment in-vivo, we had fed C. elegans AU37 with E. coli
O157:H7 (we will refer to these worms as infected) for 24 hours, and transferred to
a transwell plate with live E. coli OP50 with and without treatment with ampicillin
at various concentrations. The control was C. elegans mutant AU37 infected with E.
coli OP50 (we will refer to as control) for 24 hours and treated with ampicillin in a
96 transwell plate. A previous study has been done testing EHEC pathogenicity on C.
elegans (Chou et al., 2013) however, limited studies have been performed on the
effectiveness of antibiotics using C. elegans model. Hence, minimum inhibitory
concentration test in-vitro was performed to determine the minimum ampicillin
concentration that inhibits the growth of E. coli O157:H7. Starting with in-vitro
minimum inhibitory concentration (0.25-1µg/ml), we determined the minimum
effective ampicillin concentration to treat E. coli O157:H7 infection in-vivo was much
higher (8µg/ml).
Pathogenicity of E. coli O157:H7 to C. elegans AU37 was tested, and
determined to significantly decrease in the life-span of infected worms compared to
the control worms (Figure 6A). The result indicates that E. coli O157:H7 is
pathogenic to the C. elegans strain AU37. Treatment with ampicillin was tested on
infected worms and determined that the worms fed with ampicillin concentration
8µg/ml, 16µg/ml, and 32µg/ml after being infected for 24 hours with an initial
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infection of 2.4 x 102 CFU/worm, shows significant increase in the life-span of
infected worms (Figure 6 (B-D)). This indicates that ampicillin concentration
8µg/ml, 16µg/ml, and 32µg/ml are effective in treating E. coli O157:H7 infection in
C. elegans strain AU37. Control worms were fed with ampicillin concentration
8µg/ml, 16µg/ml, and 32µg/ml in 96 transwell plate to ensure ampicillin
concentrations was toxic to the worms (results not shown). The control results are
contradictory, as ampicillin did not affect the life-span of the worms in a first trial,
whereas ampicillin decreases the life-span of the worms compared to the control in
a second trial. However, the treatment with ampicillin on infected worms did not
appear as toxic, since the life-span of the infected worms treated with ampicillin
survived significantly more than infected alone (Figure 6 (B-D)) and mimiced the
survival of the control worms (not shown). Further studies on the appearance of the
worms (body size and shape) and its activity (movement and pharyngeal pumping)
need to study to enlighten the effect of ampicillin on C. elegans strain AU37.
Intestinal bacterial colonization assay was performed on infected and
ampicillin treated worms to determine whether the ampicillin treatment reduced
the bacterial colonization overtime in worms intestine. Approximately 10 worms
were used to determine the intestinal bacterial colonization. Treatment with
ampicillin dose 16µg/ml and 32µg/ml significantly decreased intestinal bacterial
colonization in the worms (1.38 log) compared to the infected worms without
ampicillin treatment (Figure 6E). The results indicates that E21B has colonized and
replicated in worms intestine, which supports the findings of Chou et al. (2013);
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and the treatment with ampicillin decreased the intestinal bacterial colonization in
the worms. The experiment was performed twice (independently) with the
significant result when infected worms were treated with ampicillin. These findings
suggest C. elegans as an appropriate model to use as an in-vivo model to study
bacterial infection and its treatment. However, there was variability on the life-span
of the worms between both trials. This could possibly be due to the initial infection
in the worms intestine (4.9 x 102 CFU/worm in first trial compared to 2.4 x 102
CFU/worm for the results shown). In both experiments, worms were fed with the
same number of bacteria, however, the number of bacteria eaten by worms varies
and could then influence the life-span.
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Figure 6 C. elegans AU37 infection with E. coli O157:H7 (E21B) in a liquid medium
using ampicillin treatment. C. elegans were grown to L4/ young adults and
transferred to 24 well plate containing »109 CFU E. coli O157:H7 and »109 CFU E.
coli OP50 (control) per 1ml M9 buffer (v/v). Worms were fed with E21B and OP50
for 24 hours in an M9 buffer. Worms were transferred to 96 transwell plate and fed
with live E. coli OP50 and ampicillin (0µg/ml, 8µg/ml, 16µg/ml, and 32µg/ml).
GraphPad Prism 7 was used to obtain the p-value and T50 (Table 2) (A) Life-span of
control worms (OP50) and infected worms (E21B) without ampicillin treatment. (B)
Life-span of infected worms with 8µg/ml ampicillin (Amp 8) and without ampicillin
(E21B) treatment. (C) Life-span of infected worms with 16µg/ml ampicillin (Amp
16) and without ampicillin (E21B) treatment. (D) Life-span of infected worms with
32µg/ml ampicillin (Amp 32) and without ampicillin (E21B) treatment. (E)
Intestinal colonization of infected worms at Day 0 and worms with and without
ampicillin treatments (E21B, Amp 8, Amp 16, Amp 32) at Day 24, the dotted line
indicated minimum detectable level (1 x 101 CFU/worm).
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Table 2 Statistical summary of C. elegans AU37 infection with E21B
P-value compared to E21B
without treatment
GehanBreslow- Significant?
Wilcoxo
n test

Infection

Ampicillin
Treatment
(µg/ml)

Median
life-span
T50 (days)

Logrank
(MantelCox) test

E. coli OP50

0

20

0.0208

0.0236

Yes

E. coli E21B

0

18

NA

NA

NA

E. coli E21B

8

22

0.0047

0.0075

Yes

E. coli E21B

16

22

0.0002

<0.0001

Yes

E. coli E21B

32

20

0.0001

0.0002

Yes

GraphPad Prism 7 for Mac OS was used to obtain statistical summary on C. elegans
AU37 infection with E21B in a liquid medium using ampicillin treatment. The pvalue confirms the life-span study (Figure 4 (A-D)) is significant. T50 indicates that
the worms treated with ampicillin (8µg/ml and 16µg/ml) have significantly higher
survival rate compared to the worms without treatment. A p-value less than 0.05 is
significant. T50 defines as a time taken when 50% of the worms died.

28

5.4 Heat stress is not an effective way to reduce the life span of AU37
It is known heat stress reduces life-span of the worms, hence, experimental
time, imitating the results with non-heat stress worms (Shen et al., 2017). We were
interested to see if we can shorten the experimental time and obtain our results
faster. In heat stress assay, the C. elegans incubation was held at 37°C after infection.
Heat stress assay shortens the time required to perform an infection-treatment
experiment, from days to hours (Figure 7(A-C)). However, we concluded that heat
stress is not an effective way to reduce the experimental time, as we observed
inconsistent results (Table 2). Variability in results may be due to counting error in
the liquid medium, since at 37°C worms stops movement and becomes straight,
mimicking dying posture when still alive. In addition, the growth rate of E. coli is
faster at 37°C compared to at 25°C (Olanya et al., 2014), thus it may be a
combination of stressed C. elegans and increased infection rate by E. coli O157:H7.
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Figure 7 Heat stress assay. The procedure for the infection-treatment assay was
same as section 5.3, except the incubation temperature, which was 37°C. (A) Lifespan of infected (E21B) and non-infected (OP50) C. elegans strain AU37, without
ampicillin treatment. (B) Life-span of infected worms with 16µg/ml ampicillin (Amp
16) and without ampicillin (E21B) treatment. (C) Life-span of infected worms with
32µg/ml ampicillin (Amp 32) and without ampicillin (E21B) treatment.
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Table 3 Heat stress assay

Infection

Ampicillin
Treatment
(µg/ml)

Median
life-span
T50
(Hours)

Experiment 1
P-value compared to
E21B
Log-rank
(MantelCox) test

GehanBreslowWilcoxo
n test

Median
Experiment 2
lifeP-value compared to
span
E21B
T50
Significant?
Significant?
(Hours Log-rank Gehan(Mantel- Breslow)
Cox) test Wilcoxo
n test

E. coli
OP50

0

4

0.0131

0.0008

Yes

5

0.0463

0.1002

Yes/ No

E. coli
E21B

0

1

NA

NA

NA

3

NA

NA

NA

E. coli
E21B

8

NA

NA

NA

NA

3

0.6473

0.5072

No

E. coli
E21B

16

1

0.0954

0.0232

No/ Yes

3

0.9106

0.9233

No

E. coli
E21B

32

1

0.3133

0.0254

No/ Yes

NA

NA

NA

No

GraphPad Prism 7 for Mac OS was used to obtain statistical summary on heat stress assay. Non-infected worms (E. coli OP50)
and infected worms with ampicillin treatment were compared with infected worms (E21B) to obtain the p-value. The p-value
using Gehan-Breslow-Wilcoxon test confirms significant difference between non-infected and treated worms compared to the
infected worms in experiment 1 but not significant during experiment 2. A p-value less than 0.05 is significant.
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5.5 Effect of ampicillin treatment on AU37 fed with acid stressed E. coli
O157:H7 cells
The C. elegans assay could be used to determine if bacterial pathogens
exposed to conditions found in foods are more or less suspetable to antibiotic
treatment in-vivo. An acid-stressed experiment was performed because of the
concern that for EHEC infection the E. coli cells needs to pass through our stomach
acid, where they may encounter acid stress, in order to colonize our gut. Growth
curve was performed for E. coli O157:H7 grown in a Luria-Bertani broth at pH 6.90
and pH 5.25 to determine the estimate time required for the cells to reach late
exponential stage (Figure 8).
To determine the effect of acid-stressed E. coli O157:H7 (E21B) cells on C.
elegans infection and treatment, we had grew E21B in a Luria-Bertani broth with a
pH 5.25±0.05 (referred to as acid stressed cells) for 12-14 hours at 37°C till the
bacteria is in late exponential stage to fed the L4-stage worms. As a comparison, C.
elegans AU37 were infected with E21B grown in Luria-Bertani broth with a pH of
6.65±0.05 for 6-8 hours at 37°C. Control was C. elegans mutant AU37 fed with E. coli
OP50 grown in Luria-Bertani broth with a pH of 6.65±0.05 for 6-8 hours and pH of
5.25±0.05 for 16-18 hours at 37°C till the cells reach to the late exponential stage.
Further experimental procedure was run in the same manner as mentioned in
section 5.3.
Our results show no significant difference between infected worms fed with
E21B grown at pH 6.65±0.05 and worms fed with E21B grown at pH 5.25±0.05
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(Figure 9A). In addition, treatment with 8µg/ml and 32µg/ml ampicillin
concentration results in no significant difference in the life-span of C. elegans mutant
AU37 fed with E21B grown at pH 6.65±0.05 compared to the worms fed with E21B
grown at pH 5.25±0.05 (Figure 9 (B, D)). However, treatment with 16µg/ml
ampicillin concentration results in significantly shorter the life-span of C. elegans
AU37 fed with E21B grown at pH 5.25±0.05 compared to the worms fed with E21B
grown at pH 6.65±0.05 (p < 0.05) (Figure 9C).
Treatment with ampicillin did not increase the life-span of infected worms
fed with E21B at either pH compared to the infected worms without treatment
(Figure 10 (A-F)). However, it shows increased survival of the treated worms with
ampicillin at the median life-span (T50) compared to the infected worms with E21B
at pH 6.65±0.05. These results indicate that there can be variablity in this test
system, since previously (Section 5.3), we found the ampicillin treatment increased
the life-span of infected worms. Differences in this result may be due to higher initial
infection per worm in this experiment (8.3 x 102 CFU/ worm compared to 2.4 x 102
CFU/worm). Another possiblity, may be due to the use of late exponential stage E.
coli O157:H7 cells in this set of experiments, compared to the use of stationary
phase E. coli O157:H7 cells in section 5.3. The last reason could be due to the age of
our stock C. elegans culture due to the storage at 15°C. Despite not seeing a
statistical increase in life-span, ampicillin treatment decreased the number of
bacterial counts in worms intestine (Figure 9E). Figure 9E shows the bacterial
colonization in worms intestine at Day 14. Initial bacterial colonization at Day 0 in
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worms infected with E21B grown at pH 6.65±0.05 was 8.3 x 102 CFU/worm and in
worms infected with E21B grown at pH 5.25±0.05 was 1.6 x 103 CFU/worm. At day
14, ampicillin treatment with 16µg/ml decreased the intestinal colonization of
worms fed with E21B grown at pH 5.25±0.05 by approximately 1.8 log compared to
the 1 log reduction in the worms fed with E21B grown at pH 6.65±0.05, however
failed to increase the life-span of the infected worms. Further study is needed to
understand such effect on the life-span of worms.

10

Time (hours)
1

Absorbance at 625nm

0

5

10

15

20

0.1

25

30

pH = 6.90
pH = 5.25

0.01

0.001

0.0001

Figure 8 E. coli O157:H7 growth curve at pH 6.90 vs at pH 5.25. Blue curve is the
growth of E. coli O157:H7 in a Luria-Bertani broth pH 6.90 at 37°C. Red curve is the
growth of E. coli O157:H7 in a Luria-Bertani broth pH 5.25 at 37°C.
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Figure 9 Effect of ampicillin treatment on C. elegans AU37 fed with E21B grown on
pH 6.65 vs. E21B grown on pH 5.25. C. elegans were grown to L4/ young adults and
transferred to 24 well plate containing »109 CFU E21B grown at pH 6.65±0.05 and
»109 CFU E21B grown at pH 5.25±0.05 per 1ml M9 buffer (v/v). Worms were fed
with E21B for 24 hours in an M9 buffer. Worms were transferred to 96 transwell
plate and fed with live E. coli OP50 and ampicillin (0µg/ml, 8µg/ml, 16µg/ml, and
32µg/ml). GraphPad Prism 7 was used for statistical analysis. (A) Life-span of
infected worms without ampicillin treatment. (B) Life-span of infected worms with
8µg/ml ampicillin treatment. (C) Life-span of infected worms with 16µg/ml
ampicillin treatment. (D) Life-span of infected worms with 32µg/ml ampicillin
treatment. (E) Intestinal colonization of infected worms at Day 14 with and without
ampicillin treatments (E21B, Amp 8, Amp 16, Amp 32), the dotted line indicates
minimum detectable level (1 x 101 CFU/worm).
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Figure 10 Effect of ampicillin treatment on C. elegans AU37 fed with E21B grown on
pH 6.65 and E21B grown on pH 5.25. C. elegans were grown to L4/ young adults and
transferred to 24 well plate containing 109 CFU E21B grown at pH 6.65 and 109 CFU
E21B grown at pH 5.25 per 1ml M9 buffer (v/v). Worms were fed with E21B for 24
hours in an M9 buffer. Worms were transferred to 96 transwell plate and fed with
live E. coli OP50 and ampicillin (0µg/ml, 8µg/ml, 16µg/ml, and 32µg/ml). GraphPad
Prism 7 was used for statistical analysis. (A) Life-span of infected worms fed with
E21B grown at pH 6.65 (Infected pH 6.65) and treated with 8µg/ml ampicillin (Amp
8 pH 6.65). (B) Life-span of infected worms fed with E21B grown at pH 6.65
(Infected pH 6.65) and treated with 16µg/ml ampicillin (Amp 16 pH 6.65). (C) Lifespan of infected worms fed with E21B grown at pH 6.65 (Infected pH 6.65) and
treated with 32µg/ml ampicillin (Amp 32 pH 6.65). (D) Life-span of infected worms
fed with E21B grown at pH 5.25 (Infected pH 5.25) and treated with 8µg/ml
ampicillin (Amp 8 pH 5.25). (E) Life-span of infected worms fed with E21B grown at
pH 5.25 (Infected pH 5.25) and treated with 16µg/ml ampicillin (Amp 16 pH 5.25).
(F) Life-span of infected worms fed with E21B grown at pH 5.25 (Infected pH 5.25)
and treated with 32µg/ml ampicillin (Amp 32 pH 5.25).
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CHAPTER 6
CONCLUSIONS

In conclusion, C. elegans needs live E. coli OP50 to get enough nutrients to
grow and survive. C. elegans strain AU37 is more suitable compared to N2 strain for
the E. coli O157:H7 infection-treatment assay, as AU37 is more susceptible to
bacterial infection compared to wild-type N2 strain.
Our results indicate that C. elegans is an appropriate model to use as an invivo study for EHEC infection and treatment as E. coli O157:H7 colonize the worm’s
intestine and the treatment with ampicillin concentration 8µg/ml, 16µg/ml, and
32µg/ml significantly increases the life-span of the worms compared to the infected
worms without ampicillin treatment.
In contrast, when ampicillin treatment was used on acid-stressed and nonacid-stressed late exponential stage E. coli O157:H7 cells, it failed to increase the
life-span of the worms infected with acid-stressed and non-acid stressed E. coli
O157:H7 cells. This may possibly be due to the use of late exponential stage E. coli
O157:H7 cells compared to the use of stationary phase E. coli O157:H7 cells in the
previous experiment. In addition, ampicillin treatment with concentration 16µg/ml
on C. elegans infected with acid-stressed E. coli O157:H7 cells significantly reduces
the life-span of the worms compared to the ampicillin treated (16µg/ml) non-acid
stressed E. coli O157:H7 cells, even though ampicillin reduces the intestinal bacterial
colonization to approximately 1.8 log compared to approximately 1 log for non-acid
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stressed E. coli O157:H7. Hence, further studies need to perform to understand such
effect on the life-span of the worms.
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APPENDIX
EXPANDED LAB PROCEDURES
E. COLI O157:H7 INFECTION-TREATMENT IN C. ELEGANS PROCEDURE

1. Preparation of nematode growth media (NGM) plate and concentrated
E. coli OP50
• Prepare NGM plate and concentrated E. coli OP50 a week before the start of
the experiment.
A. NGM plate seeded with OP50 preparation
o Prepare NGM plate using NGM growth media and follow the manufacture
instructions.
o Grow E. coli OP50 in a Luria-Bertani broth for 12-14 hours at 37°C and
pipet 1ml onto each of the 2 days old NGM plate. Let the plate sit at the
room temperature for another two days. This is referred to as OP50
seeded NGM plates. Store the plates at 4°C till ready to use.
B. Concentrated E. coli OP50
o Grow E. coli OP50 in a Luria-Bertani broth for 12-14 hours at 37°C and
centrifuge using a 50ml centrifuge tube, collect the pellet and discard the
supernatant
o Weigh the pellet and prepare 100 mg/ml OP50 concentration using sterile
water. This is referred to as concentrated OP50 for C. elegans food in 96
transwell plate.
2. C. elegans stock culture preparation
• Chunk a piece of agar containing many AU37 worms received from CGC or
from your old NGM plate containing AU37 worms and place it onto your
freshly prepared NGM agar seeded with OP50. Incubate the plate at 15°C.
Plate can be stored at 15°C for up to 4 months and can be used when needed.
3. Infection-Treatment life-span assay using C. elegans strain AU37
Day 1: Chunk a piece of NGM agar
• Chunk a piece of agar containing many AU37 worms and transfer it onto
three new NGM plates seeded with OP50. Incubate the plates at 15°C for
approximately 4 days for the worms to lay eggs.
Day 5: Collect the eggs (synchronization of worms)
• Wash each of the NGM plates having many eggs with approximately 3 ml
sterile water for couple of time. Dispense the washed liquid containing
worms into 15ml centrifuge tube.
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•
•
•

•
•

Centrifuge at 2000g for 2mins. Discard the supernatant.
Prepare 10ml bleach solution (1ml 10M NaOH, 1.8ml household bleach, and
7.2ml sterile water) into a 15ml centrifuge tube (You can prepare 5ml or
10ml bleach depends on the density of worms you have).
Add the bleach solution to the washed worms tube, and vortex at high speed
for 2mins. Centrifuge at 2000g for 1min and discard the supernatant. Add
approximately 10ml M9 buffer to neutralize the bleach effect and vortex
little (All this process in this step should be really fast, should not exceed
>3.5 mins, or the eggs won’t hatch out the next day), and then centrifuge at
2000g for 2mins, and discard the supernatant. At this stage you should have
only eggs in your tube (may contains few dead worms).
Add 10ml M9 buffer one more time and centrifuge at 2000g for another
2mins, discard the supernatant, and add 1ml of M9 buffer.
Incubate the centrifuge tube containing eggs horizontally at 25°C for 24
hours for the eggs to hatch out. After 24 hours the worms should be in L1
stage.

Day 6: Transfer of L1 stage worms and E21B streak plate
A. Transfer the L1 stage worms using a pipet onto NGM plate seeded with OP50
and incubate the plate at 25°C for 45-50 hours. Worms should be at L4-young
adult stage after 45-50 hours.
B. Streak a new Tryptic Soy Agar (TSA) plate from a frozen E21B stock and
incubate at 37°C for 18-20 hours. Follow the same procedure with OP50.
Day 7: E21B and OP50 culture preparation
• Transfer 3 colonies from streaked E21B from Day 6 into two 10ml LuriaBertani broth. Incubate the tubes at 37°C for 18-20 hours on a 125rpm
shaker. Follow the same procedure with OP50.
Day 8: Infecting worms with E21B
A. Preparation of E21B and OP50 culture
• Take out E21B and OP50 culture tubes from Day 7, dilute the culture 10x,
and read the absorbance at wavelength 625nm using spectrophotometer.
Absorbance of 0.08 – 0.1 at wavelength 625nm is consider having
approximately 108 CFU/ml bacteria.
• Centrifuge the original 9 ml E21B and OP50 culture containing
approximately 109 CFU/ml bacteria at 2500g for 10 minutes and discard the
supernatant.
• Add 0.9 ml M9 buffer to each tube to make the final bacterial concentration of
1010 CFU/ml.
B. Preparation of worms
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•

•
•

Pipet approximately 2-3ml M9 buffer into each of the Day 6 plates containing
synchronized L4-young adult stage AU37 worms and collect it into a 15ml
centrifuge tube. Centrifuge the worms at 2000g for 1min with M9 buffer
three times to remove any OP50 residue. Discard the supernatant using
pipet.
Add 1ml of M9 buffer and transfer the mixture into 2ml micro centrifuge
tube.
Pipet five 10 µl drops on a sterile petri dish and count the number of worms.
Average the worms per 10 µl and record the number.

C. Infection in 24 well plate
• Add approximately 100 worms into 24 well plate and make the final volume
to 900 µl using M9 buffer.
• Add 100 µl E21B to make the final E21B concentration of 109 CFU/ml. Run
control on side by adding 100 µl OP50 to make the final OP50 concentration
of 109 CFU/ml.
• Incubate the plate at 25°C for 24 hours.
Day 9: Treatment with ampicillin
A. Preparation of bacterial food with varied ampicillin concentration
• Add concentrated OP50 to the final concentration of 3mg/ml and ampicillin
to the final desired concentration using M9 buffer in a sterile tube. Mix the
mixture well for 1min using vortex at high speed.
• Add 250 µl of the food mixture to the bottom of 96 transwell plate.
B. Preparing and adding worms to use in 96 transwell plate
• Transfer infected worms (E21B) from Day 8 into 15ml centrifuge tube.
Follow same procedure for control (OP50) worms.
• Centrifuge the worms at 2000g for 1 minute and discard the supernatant.
Add M9 buffer and repeat the procedure five times to remove most residue of
E21B and OP50.
• Pipet five 10µl drops of each of the infected and control worms into a sterile
petri dish to determine the number of worms per 10µl. Average and record
the number.
• Transfer approximately 10 infected worms into a micro centrifuge tube to
determine the bacterial colonization in worms’ intestine.
• Transfer approximately 10 worms into each of the insert well in transwell
plate containing food in the bottom wells.
• Incubate the plate at 25°C and record the number of viable worms every day
to every other day.
C. Bacterial colonization in the worms
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•
•
•
•
•
•

Add 1mM sodium azide to the final volume of 250µl into approximately 10
infected worms tube.
Centrifuge the worms at 2000g for 1min and discard the supernatant using
pipet. Add 1mM sodium azide to the final volume of 250µl and repeat the
step 3 times.
Add 50µl of supernatant to the Sorbitol MacConkey Agar to determine the
external bacterial count.
Add approximately 400mg of 1mm silicon carbide particles into the tube
containing 10 infected worms and vortex at high speed for 1min to disrupt
the worms.
Perform serial dilution and plate onto Sorbitol MacConkey Agar to determine
total bacterial count (Internal + External) per 10 worms.
Incubate the plates at 37°C for 18-20 hours.
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